RBC disorders Flashcards
Anemia is defined as a reduction in
red cell mass, with consequent decrease in oxygen transport capacity of the blood.
Clinical parameters used in testing for anemia include
red cell count, hemoglobin concentration, and hematocrit, all of which reflect, but do not directly measure, the red cell mass.
Accepted “normal” RBC levels vary with
age, sex, and geographic location.
Clinically, anemia results in impaired
tissue oxygenation as manifest by exertional shortness of breath, weakness, fatigue, and pallor.
Polycythemia denotes an
increase in red cell mass.
Anemias can be classified into three broad categories based on the mechanism by which red cell mass is decreased:
blood loss, decreased red cell production, and decreased red cell survival.
Other Anemia classification systems based on
red cell morphology are also in common use.
RBC (Blood) Loss
Hemorrhage
Trauma (acute)
GI or GYN disease
Decreased RBC Survival
Mechanical trauma transfusion reactions hereditary spherocytosis hemoglobinopathies thalassemias G6PD deficiency Erythroblastosis fetalis Malaria
Decreased RBC Production
Iron deficiency anemia Vitamin B12 deficiency Folate deficiency Aplastic anemia Myelophthisic anemias
Young healthy subjects can tolerate rapid blood loss of
500-1000 mL (up to 15-20% of total blood volume) with few symptoms, but some will have a vasovagal response- sweating, weakness, nausea, slow heart rate, hypotension.
If blood loss is controlled, interstitial fluid will
redistribute (within 24 hours) into the vascular space in an attempt to re-expand the vascular volume.
Loss of 1000-1500 mL produces
lightheadedness, orthostatic hypotension;
with loss of 1500-2000 mL, all patients are
symptomatic- thirst, shortness of breath, loss of consciousness, sweating, rapid pulse, decreased blood pressure, clammy skin.
Rapid loss of 2000-2500 mL produces
shock.
The loss of RBC stimulates
increased production, mediated by erythropoietin, resulting in an increase in the reticulocyte count in the peripheral blood.
Chronic blood loss causes anemia when the rate of loss
exceeds the capacity for RBC regeneration or when iron reserves are depleted.
Chronic GI hemorrhage due to ulcer or neoplasm, or GYN hemorrhage (menorrhagia) are important causes of
iron deficiency.
Hemolytic anemias are characterized by
shortened red cell survival and retention of products of red cell destruction (iron).
Increased erythropoietin production results in increased
red cell production with a reticulocytosis to compensate for the anemia.
Red cell destruction can occur within the
circulation (intravascular hemolysis) or in the reticuloendothelial system including spleen (extravascular hemolysis).
Intravascular hemolysis: destruction of
RBC within the circulation. Examples: mechanical trauma (e.g., from a defective heart valve), hemolytic transfusion reaction.
Hemoglobin released from RBC into circulation (hemoglobinemia) is bound to
haptoglobin, a binding protein, and cleared from the circulation by the liver.
A decrease in serum haptoglobin is a key feature of
intravascular hemolysis.
When plasma hemoglobin levels exceed amount of available haptoglobin, free hemoglobin is
excreted in the urine (hemoglobinuria); however hemoglobin is toxic to the kidney, and iron that accumulates in proximal tubular cells in the kidney as a breakdown product of hemoglobin is lost in the urine when these cells are shed (hemosiderinuria).
Conversion of heme (derived from hemoglobin) to bilirubin leads to
hyperbilirubinemia and jaundice. The degree of jaundice is dependent on the functional capacity of the liver and rate of hemolysis. Levels of haptoglobin are characteristically low.
Intravascular hemolysis: • Immune
–
Transfusion reaction
Intravascular hemolysis: • Non-immune
– Mechanical trauma (defective heart valve)
Extravascular hemolysis: destruction of RBC in
reticuloendothelial system (spleen, liver). Examples: Hereditary spherocytosis, sickle cell anemia, erythroblastosis fetalis (antibody-mediated hemolytic disease of the newborn).
Damaged or abnormal RBC are removed in
spleen, where hemoglobin is broken down intracellularly.
Free hemoglobin is not released from spleen directly into
the blood and urine, but hemoglobin breakdown products are increased (hyperbilirubinemia) and jaundice may result.
Spleen and liver may become enlarged since these are sites of
removal of RBC from the circulation.
Chronically elevated levels of bilirubin can promote formation of
gallstones.
Hemolytic anemias are classified by the mechanism of
red cell destruction into intrinsic defects (hemoglobin production, membrane abnormality) which are usually inherited, and extrinsic defects (antibody, mechanical trauma) which are usually acquired abnormalities.
Intrinsic: Membrane defects: Example: hereditary spherocytosis –
extravascular hemolysis. An inherited defect in the red cell membrane results in less deformability of RBC, so that they are sequestered and destroyed in the spleen.
Hereditary spherocytosis: The specific defect can be a qualitative or quantitative deficiency of
spectrin, a structural protein of the cytoskeleton.
Hereditary spherocytosis is —————- inheritance in most cases.
Autosomal dominant
Hereditary spherocytosis: Manifest in
adult life, severity is variable.
Hereditary spherocytosis: Removal of spleen results in
normal red cell survival but not normal red cell morphology. Production of spherocytes continues, but following splenectomy their destruction is decreased
Abnormal hemoglobin: Example: sickle cell anemia –
extravascular hemolysis. An inherited defect (autosomal codominant) in the structure of globin chain causes hemoglobin to gel upon deoxygenation.
Sickle cell: The specific defect is a
single base pair substitution in DNA that causes a single amino acid substitution (valine for glutamic acid) at position 6 in the beta chain of globin to produce sickle hemoglobin (HbS).
Sickle cell: Under low oxygen conditions the abnormal hemoglobin
polymerizes, causing the RBC to assume a “sickle” shape.
Sickle cell: The sickled cells are rigid and vulnerable to
splenic sequestration (decreased survival), and can also block the microcirculation causing ischemia and/or infarction.
Sickle Cell: Sickle cell disease occurs in
homozygotes for HbS, and is characterized by severe anemia, and vaso-occlusive crises, including acute chest syndrome and stroke.
Sickle cell: Complications may also include
autosplenectomy, painful crises, leg ulcers, retinal and renal thromboses.
About 8% of blacks in USA have
sickle cell trait (heterozygotes), and are essentially asymptomatic because less than half of the hemoglobin is abnormal and the concentration of HbS within the RBC is insufficient to cause sickling.
There is a Small but significant resistance to malaria with
sickle cells.
Lack of globin chains: Example: thalassemia
– extravascular hemolysis. An inherited defect (autosomal codominant) that results in diminished or absent synthesis of either the alpha or beta globin chains of hemoglobin.